Hetero
-
{
- All
- News
- Videos
-
JSW Energy To Acquire Assets From Hetero Group For Rs 630 Crore
- Saturday October 19, 2024
- Author: Vishwanath Nair
The renewable energy projects are operating primarily in Andhra Pradesh and Maharashtra, and all the projects have long-term power purchase agreements.
-
www.ndtvprofit.com
-
US-Based Gilead Licenses Hepatitis C Drug to Cipla, Ranbaxy, 5 Others
- Thursday December 7, 2023
- Author: NDTV Profit Desk
US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India.
-
www.ndtvprofit.com
-
Apollo to Acquire HMSL's Pharmacy Stores for About Rs 146 Crore
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The acquisition would be in the form of purchase of the business undertaking on a slump sale basis and comprises of 320 pharmacy stores, at an overall consideration not exceeding Rs 146 crore, it added.
-
www.ndtvprofit.com
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
- Saturday February 19, 2022
- India News | Press Trust of India
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
www.ndtv.com
-
Rs 550-Crore "Unaccounted" Income Found During Tax Raids On Hetero Pharma Group: Report
- Saturday October 9, 2021
- India News | Press Trust of India
The Income Tax Department detected "unaccounted" income of Rs 550 crore and seized over Rs 142 crore cash after it recently raided Hyderabad-based Hetero pharmaceutical group, official sources claimed on Saturday.
-
www.ndtv.com
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
- Monday September 6, 2021
- India News | Reuters
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
www.ndtv.com
-
Reduces Hospitalisation, Says Merck Of COVID-19 Drug, Seeks India's Ok
- Friday July 9, 2021
- India News | Reuters
India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce hospitalisations and speed up recovery in mild cases.
-
www.ndtv.com
-
Maharashtra, Delhi Among 5 States To Receive First Batch Of COVID-19 Drug
- Friday June 26, 2020
- India News | Reported by Parimal Kumar, Edited by Arun Nair
Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.
-
www.ndtv.com
-
Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
- Wednesday June 24, 2020
- India News | Reuters
Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
-
www.ndtv.com
-
Indian Medicine Firm Pulls Heart Drug From US Amid Cancer Risk Probes
- Saturday August 11, 2018
- India News | Reuters
A unit of India's Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.
-
www.ndtv.com
-
Bengaluru-Based Puravankara Sells Land In Hyderabad For Rs 475 Crore
- Tuesday March 28, 2017
- Press Trust of India
Puravankara Ltd has already launched housing projects on 20 acres of land parcel in Hyderabad and is also constructing commercial projects on over three acres of land.
-
www.ndtvprofit.com
-
Lupin, 5 Other Pharma Firms Ink Licensing Pact With Medicines Patent Pool
- Thursday July 7, 2016
- Press Trust of India
Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among the seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs.
-
www.ndtvprofit.com
-
Hetero Launches Colorectal Cancer Drug In India
- Monday June 27, 2016
- Thomson Reuters
Drug firm Hetero on Monday launched a biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under the brand name 'CizumabTM'.
-
www.ndtvprofit.com
-
Germany's Stada Agrees Oncology Deal With Hetero Drugs
- Thursday March 26, 2015
- Thomson Reuters
German generics drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
-
www.ndtvprofit.com
-
JSW Energy To Acquire Assets From Hetero Group For Rs 630 Crore
- Saturday October 19, 2024
- Author: Vishwanath Nair
The renewable energy projects are operating primarily in Andhra Pradesh and Maharashtra, and all the projects have long-term power purchase agreements.
-
www.ndtvprofit.com
-
US-Based Gilead Licenses Hepatitis C Drug to Cipla, Ranbaxy, 5 Others
- Thursday December 7, 2023
- Author: NDTV Profit Desk
US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India.
-
www.ndtvprofit.com
-
Apollo to Acquire HMSL's Pharmacy Stores for About Rs 146 Crore
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The acquisition would be in the form of purchase of the business undertaking on a slump sale basis and comprises of 320 pharmacy stores, at an overall consideration not exceeding Rs 146 crore, it added.
-
www.ndtvprofit.com
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
- Saturday February 19, 2022
- India News | Press Trust of India
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
www.ndtv.com
-
Rs 550-Crore "Unaccounted" Income Found During Tax Raids On Hetero Pharma Group: Report
- Saturday October 9, 2021
- India News | Press Trust of India
The Income Tax Department detected "unaccounted" income of Rs 550 crore and seized over Rs 142 crore cash after it recently raided Hyderabad-based Hetero pharmaceutical group, official sources claimed on Saturday.
-
www.ndtv.com
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
- Monday September 6, 2021
- India News | Reuters
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
www.ndtv.com
-
Reduces Hospitalisation, Says Merck Of COVID-19 Drug, Seeks India's Ok
- Friday July 9, 2021
- India News | Reuters
India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce hospitalisations and speed up recovery in mild cases.
-
www.ndtv.com
-
Maharashtra, Delhi Among 5 States To Receive First Batch Of COVID-19 Drug
- Friday June 26, 2020
- India News | Reported by Parimal Kumar, Edited by Arun Nair
Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.
-
www.ndtv.com
-
Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
- Wednesday June 24, 2020
- India News | Reuters
Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
-
www.ndtv.com
-
Indian Medicine Firm Pulls Heart Drug From US Amid Cancer Risk Probes
- Saturday August 11, 2018
- India News | Reuters
A unit of India's Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.
-
www.ndtv.com
-
Bengaluru-Based Puravankara Sells Land In Hyderabad For Rs 475 Crore
- Tuesday March 28, 2017
- Press Trust of India
Puravankara Ltd has already launched housing projects on 20 acres of land parcel in Hyderabad and is also constructing commercial projects on over three acres of land.
-
www.ndtvprofit.com
-
Lupin, 5 Other Pharma Firms Ink Licensing Pact With Medicines Patent Pool
- Thursday July 7, 2016
- Press Trust of India
Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among the seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs.
-
www.ndtvprofit.com
-
Hetero Launches Colorectal Cancer Drug In India
- Monday June 27, 2016
- Thomson Reuters
Drug firm Hetero on Monday launched a biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under the brand name 'CizumabTM'.
-
www.ndtvprofit.com
-
Germany's Stada Agrees Oncology Deal With Hetero Drugs
- Thursday March 26, 2015
- Thomson Reuters
German generics drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
-
www.ndtvprofit.com